Thus far, approximately 40 companies worldwide, including Codiak Biosciences, Evox Therapeutics, Tavec Pharmaceuticals, Carmine Therapeutics, Anjarium, and Micromedmark Biotech, have developed exosome-based therapies, which are expected to provide cost-effective and more accurate targeted therapies in the clinic ( However, challenges, such as large-scale production, purity, and batch homogeneity of exosomes, still limit their clinical application
Ascorbic acid (vitamin C) supports carnitine biosynthesis
Pantethine is generally well tolerated in doses up to 1,200 mg/day
is a Scholar of the Leukemia and Lymphoma Society and is supported by the US NIH NIDDK R01-DK101989-01A1
& Huang, J.-R